medigraphic.com
ISSN 1665-2576 (Impreso)

2015, Número 1-4

<< Anterior Siguiente >>

Rev Mex Cir Endoscop 2015; 16 (1-4)


Remisión a mediano plazo de la diabetes mellitus tipo 2 posterior a cirugía bariátrica en mexicanos: bypass gástrico laparoscópico versus gastroplastia vertical en manga

Zerrweck-López C, Pereyra-Talamantes A, Maydón-González HG, Fernández-Silva I, Campos-Pérez F, Guilbert-Vertiz L

Idioma: Español
Referencias bibliográficas: 33
Paginas: 13-18
Archivo PDF: 222.37 Kb.


RESUMEN

Antecedentes: La diabetes mellitus tipo 2 y la obesidad están asociadas, observándose aumento de la prevalencia en mexicanos. La cirugía bariátrica ha demostrado ser el mejor tratamiento para la remisión de la diabetes asociada con la obesidad; actualmente no existen estudios en población mexicana. El objetivo fue analizar y comparar la remisión de diabetes a mediano plazo entre diferentes procedimientos y la pérdida de peso. Material y métodos: Análisis retrospectivo de 84 pacientes con obesidad y diabetes sometidos a bypass gástrico laparoscópico (n = 62) o gastrectomía vertical en manga (n = 22) entre el año 2009 y 2011 en una sola institución. Resultados: El 72.6% de los pacientes fueron mujeres. Ambos grupos presentaron un perfil metabólico preoperatorio comparable. Ambos grupos mejoraron los niveles de glucosa y Hb1Ac%, de los 12 hasta los 18 meses sin diferencias significativas. Se observó remisión en el 76.1% de pacientes; completa en 65.4% y parcial en 10.7%, sin diferencias entre grupos. La pérdida de peso fue mayor para el bypass gástrico. Discusión: Encontramos que ambos procedimientos son igualmente efectivos en hispanos para la remisión a mediano plazo de la DM2, y comparables a lo descrito en otras poblaciones. Conclusiones: Ambos procedimientos generaron remisión de la diabetes en la población mexicana a mediano plazo. No se observaron diferencias en la remisión parcial y completa entre procedimientos. El bypass gástrico mostró mayor pérdida de peso.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011; 378: 31-40.

  2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. [consultado 16 de febrero del 2015]. Available in: http://www.cdc.gov/diabetes/statistics/prev/national/figbyhispanic.htm

  3. Barquera S, Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Rivera-Dommarco JA. Prevalencia de obesidad en adultos mexicanos, 2000-2012. Salud Pública Méx. 2013; 55: S151-S160.

  4. Sudan R, Winegar D, Thomas S, Morton J. Influence of ethnicity on the efficacy and utilization of bariatric surgery in the USA. J Gastrointest Surg. 2014; 18: 130-136.

  5. Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS. The control of diabetes mellitus (NIDDM) in the morbidly obese with the greenville gastric bypass. Ann Surg. 1987; 206: 316-323.

  6. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-350; discussion 350-2.

  7. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE et al How do we define cure of diabetes? Diabetes Care. 2009; 32: 2133-2135.

  8. Pournaras DJ, Aasheim ET, Sovik TT, Andrews R, Mahon D, Welbourn R et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012; 99: 100-103.

  9. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ. 2013; 347: f5934.

  10. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery versus conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014; 24: 437-455.

  11. Heindorff H, Hougaard K, Larsen PN. Laparoscopic adjustable gastric band increases weight loss compared to dietary treatment: a randomized study. Obes Surg. 1997; 7: 300-301.

  12. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013; 101: 50-56.

  13. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366: 1577-1585.

  14. Schauer PR, Kashyap SR, Wolski K, Brethauer S, Kirwan J, Pothier C et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366: 1567-1576.

  15. Saydah S, Tao M, Imperatore G, Gregg E. GHb level and subsequent mortality among adults in the U.S. Diabetes Care. 2009; 32: 1440-1446.

  16. Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013; 23: 770-775.

  17. Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013; 23: 1994-2003.

  18. Nosso G, Angrisani L, Saldalamacchia G, Cutolo P, Cotugno M, Lupoli R et al. Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes. 2011; 2011: 340867.

  19. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011; 146: 143-148.

  20. Abbatini F, Capoccia D, Casella G, Soricelli E, Leonetti F, Basso N. Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy. Surg Obes Relat Dis. 2013; 9: 498-502.

  21. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008; 18: 1077-1082.

  22. Residori L, Garcia-Lorda P, Flancbaum L, Pi-Sunyer FX, Laferrere B. Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg. 2003; 13: 333-340.

  23. Bermudez OI, Tucker KL. Total and central obesity among elderly Hispanics and the association with Type 2 diabetes. Obes Res. 2001; 9: 443-451.

  24. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 1998; 280: 356-362.

  25. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006; 29: 1585-1590.

  26. Menke A, Rust KF, Savage PJ, Cowie CC. Hemoglobin A1c, fasting plasma glucose, and 2-hour plasma glucose distributions in U.S. population subgroups: NHANES 2005-2010. Ann Epidemiol. 2014; 24: 83-89.

  27. Coleman KJ, Huang YC, Koebnick C, Reynolds K, Xiang AH, Black MH et al. Metabolic syndrome is less likely to resolve in hispanics and non-Hispanic blacks after bariatric surgery. Ann Surg. 2014; 259: 279-285.

  28. Admiraal WM, Celik F, Gerdes VE, Dallal RM, Hoekstra JB, Holleman F. Ethnic differences in weight loss and diabetes remission after bariatric surgery: a meta-analysis. Diabetes Care. 2012; 35: 1951-1958.

  29. De la Cruz-Muñoz N, Messiah SE, Arheart KL, Lopez-Mitnik G, Lipshultz SE, Livingstone A. Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J Am Coll Surg. 2011; 212: 505-511.

  30. Dixon JB, Dixon AF, O’Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med. 2003; 20:127-134.

  31. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010; 20: 1245-1250.

  32. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013; 9: 379-384.

  33. O’Rourke RW, Andrus J, Diggs BS, Scholz M, McConnell DB, Deveney CW. Perioperative morbidity associated with bariatric surgery: an academic center experience. Arch Surg. 2006; 141: 262-268.




2020     |     www.medigraphic.com